Product Overview

Cap GAG (3'OH) is a high-purity GMP-grade mRNA capping reagent manufactured in a GMP-compliant production environment with a completely animal origin-free process throughout the entire workflow. Designed for in vitro transcription (IVT) and advanced mRNA manufacturing applications, it enables efficient enzymatic capping of mRNA molecules to support the generation of high-quality mRNA products.

With strict quality control and excellent batch-to-batch consistency, Cap GAG (3'OH) is suitable for mRNA vaccine development, gene therapy research, and large-scale GMP manufacturing. It meets the requirements of the full development pipeline, from early-stage preclinical research to commercial-scale production.

Key Features

GMP-Grade Manufacturing

Produced under a GMP-compliant quality management system with comprehensive process control, ensuring high product consistency and reliability for mRNA drug development and manufacturing.

High Purity and Low Impurity Profile

Manufactured with advanced purification technologies to achieve high purity (>98%), minimize impurities, and maintain product performance in sensitive mRNA synthesis workflows.

Ultra-Low Metal Residue Control

Strict control of metal impurities supports reliable enzymatic reactions and helps meet the stringent quality requirements of mRNA manufacturing processes.

Animal Origin-Free Processing

The entire production workflow adopts an animal origin-free process, providing enhanced safety and compliance for pharmaceutical and biotechnology applications.

Flexible Supply and Customization

A complete range of mRNA capping reagents is available. Customized specifications and packaging solutions can be provided to meet different research and manufacturing requirements.

DMF Filing Support

Documentation support is available for regulatory and pharmaceutical development requirements.

Applications

Cap GAG (3'OH) is designed for applications requiring efficient and reliable mRNA capping performance, including:

• mRNA vaccine development and GMP manufacturing

• Gene therapy drug development

• In vitro transcription (IVT) reactions

• mRNA synthesis and optimization workflows

• Preclinical research and process development

• GMP-scale mRNA production

It is suitable for use throughout the mRNA drug development lifecycle, from laboratory research and process optimization to commercial manufacturing.

FAQ

Q1: What is Cap GAG (3'OH) used for?

Cap GAG (3'OH) is an mRNA capping reagent used in in vitro transcription (IVT) and mRNA manufacturing workflows. It supports the generation of capped mRNA products for applications such as mRNA vaccines and gene therapy development.

Q2: Is Cap GAG (3'OH) suitable for GMP manufacturing?

Yes. Cap GAG (3'OH) is manufactured in a GMP-compliant production environment with strict quality control procedures and supports applications from preclinical development to GMP-scale manufacturing.

Q3: Does the manufacturing process contain animal-derived materials?

No. Cap GAG (3'OH) is produced using a completely animal origin-free manufacturing process throughout the workflow.

Q4: What is the purity of Cap GAG (3'OH)?

The purity of Cap GAG (3'OH) is greater than 98%, meeting the requirements for high-quality mRNA synthesis applications.

Q5: How should Cap GAG (3'OH) be transported and stored?

Cap GAG (3'OH) should be transported under temperature-controlled conditions below 0°C and stored at -25°C to -15°C to maintain product stability and performance.

Q6: Can customized requirements be supported?

Yes. Customized specifications, packaging formats, and supply solutions can be discussed based on specific research and manufacturing needs.

Related Products